首页> 外文期刊>Journal of Perinatal Medicine >Alterations of lymphocyte subsets in patients with recurrent fetal wastage positive for antiphospholipid antibodies treated with Chinese herbal medicine.
【24h】

Alterations of lymphocyte subsets in patients with recurrent fetal wastage positive for antiphospholipid antibodies treated with Chinese herbal medicine.

机译:中草药治疗的抗磷脂抗体阳性的反复胎儿浪费患者的淋巴细胞亚群变化。

获取原文
获取原文并翻译 | 示例
           

摘要

The alterations of peripheral blood lymphocyte subsets were sequentially analyzed in patients with recurrent fetal wastage who were treated with the Chinese herbal medicine, Sairei-to (Chan ling-Tan) for positive antiphospholipid antibodies to analyze the underlying mechanisms of the therapy. The titer of antiphospholipid antibodies was significantly decreased by administration of Sairei-to at one and two months after commencement of treatment and in the newly pregnant state compared with that before administration. The percentage of CD19-positive cells significantly decreased at two months after commencement of Sairei-to treatment and at the newly pregnant state compared with that before administration in successful pregnancies. The percentage of CD4-positive cells significantly increased two months after commencement of Sairei-to treatment compared with that before administration in both successful pregnancies and total cases. The CD4/CD8 ratio was increased significantly after two months administration of Sairei-to in both successful pregnancies and total cases. Thus, it is suggested that the administration of Sairei-to might induce the predominance of CD4-positive cells in parallel with the suppression of antiphospholipid antibodies. Moreover, the suppression of CD19-positive cells (B cells) was induced by administration of Sairei-to which might be involved in successful continuation of pregnancy in the patients.
机译:顺序分析了反复胎儿流失的患者外周血淋巴细胞亚群的变化,这些患者接受了中草药Sairei-to(Chan ling-Tan)治疗的抗磷脂抗体阳性,以分析该疗法的潜在机制。与开始治疗前相比,在治疗开始后1个月和2个月内以及刚进入新孕状态,通过Sairei-to给药,抗磷脂抗体的滴度显着降低。与成功妊娠前给药相比,在开始Sairei-to治疗后两个月和刚怀孕时,CD19阳性细胞的百分比显着下降。在成功怀孕和全部病例中,Sairei-to治疗开始后两个月的CD4阳性细胞百分比与给药前相比显着增加。在成功怀孕和全部病例中,给予Sairei-to两个月后,CD4 / CD8比值显着增加。因此,提示Sairei-to的施用可能与抗磷脂抗体的抑制同时诱导CD4阳性细胞的优势。而且,通过给予Sairei-to诱导了对CD19阳性细胞(B细胞)的抑制,这可能与患者成功地继续妊娠有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号